Atherosclerotic Cardiovascular Disease
📧 Sign up to get email alerts when something new happens for Atherosclerotic Cardiovascular Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-06-12FDA Approved: EZETIMIBE — Original Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a generic ezetimibe tablet from Quallent Pharmaceuticals Health LLC under ANDA204331. Ezetimibe lowers cholesterol and is u…
-
FDA approval · 2017-05-25FDA Approved: COLESTID — Supplemental Application (Pharmacia & Upjohn Company LLC)
FDA approved a supplemental application for COLESTID (colestipol hydrochloride) submitted by Pharmacia & Upjohn Company LLC.
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Social Forces to Improve Statin Adherence (Study B) [NA]
This completed University of Pennsylvania study evaluated social-forces interventions to improve adherence to statins; results were posted i…
-
FDA approval · 2017-04-24FDA Approved: PRALUENT — Supplemental Application (Regeneron Pharmaceuticals, Inc.)
The FDA approved a supplemental application for PRALUENT (alirocumab) submitted by Regeneron Pharmaceuticals, Inc., updating the product’s l…
-
FDA approval · 2017-03-27FDA Approved: ATORVASTATIN CALCIUM — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's atorvastatin calcium as an original-application generic product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-03-21FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Ascend Laboratories, LLC)
FDA approves the original ANDA for rosuvastatin calcium from Ascend Laboratories, LLC, enabling the generic rosuvastatin calcium product to …
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects [Phase 1]
Phase 1 study evaluating the effect of rifampin on the single-dose pharmacokinetics of BMS-986141 in healthy subjects has completed.
-
FDA approval · 2017-02-03FDA Approved: PITAVASTATIN — Original Application (Upsher-Smith Laboratories, LLC)
The FDA approved an original ANDA for pitavastatin calcium from Upsher-Smith Laboratories, making a generic pitavastatin product available.
-
FDA approval · 2017-02-02FDA Approved: PRAVASTATIN SODIUM — Original Application (Aurobindo Pharma Limited)
FDA approved an original ANDA for pravastatin sodium tablets from Aurobindo Pharma Limited, providing a generic option for cholesterol manag…
-
FDA approval · 2017-01-25FDA Approved: REPATHA — Supplemental Application (Amgen USA Inc.)
The FDA page indicates a supplemental application for Repatha (evolocumab) submitted by Amgen USA Inc.; the submission status is AP.
-
FDA approval · 2017-01-23FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Pravastatin Sodium (generic) from Teva Pharmaceuticals USA, Inc. The approval confirms the c…
-
FDA approval · 2017-01-19FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) from Organon LLC.
-
FDA approval · 2017-01-03FDA Approved: REPATHA — Supplemental Application (Amgen USA Inc.)
FDA approved a supplemental application for REPATHA (evolocumab) submitted by Amgen USA Inc.
-
FDA approval · 2016-12-20FDA Approved: PITAVASTATIN — Original Application (Aurobindo Pharma Limited)
FDA approved the original Abbreviated New Drug Application for pitavastatin from Aurobindo Pharma Limited, enabling the generic to enter the…
-
FDA approval · 2016-11-23FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Cadila Pharmaceuticals Limited)
FDA approved Cadila Pharmaceuticals' rosuvastatin calcium as an original generic product (ANDA 207453) for lowering cholesterol.
-
FDA approval · 2016-11-20FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for pravastatin sodium from Aurobindo Pharma Limited (ANDA077793), authorizing continued marketing o…
-
FDA approval · 2016-11-17FDA Approved: PRAVASTATIN SODIUM — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's pravastatin sodium product via an Original Application (ANDA207068).
-
CLINICAL_TRIALS research · 2016-11-15Clinical Trial Update: A Registration Study for Dyslipidemia
This entry notes a registration study investigating dyslipidemia in patients with atherosclerotic vascular disease; the current status of th…
-
FDA approval · 2016-10-31FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Cranbury Pharmaceuticals, LLC)
FDA approved Cranbury Pharmaceuticals' rosuvastatin calcium through an Original Application for an Abbreviated New Drug Application (ANDA), …
-
FDA approval · 2016-10-31FDA Approved: ROSUVASTATIN — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's original application for rosuvastatin as a generic product. Rosuvastatin is used to treat hyperlipidemia an…
-
FDA approval · 2016-10-31FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Torrent Pharmaceuticals Limited)
FDA approved an Original Application for rosuvastatin calcium from Torrent Pharmaceuticals Limited, granting generic approval for the rosuva…
-
FDA approval · 2016-10-31FDA Approved: ROSUVASTATIN — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves rosuvastatin (generic) under an Original Application by Camber Pharmaceuticals, adding a generic statin option for lowering cho…
-
FDA approval · 2016-10-31FDA Approved: ROSUVASTATIN CALCIUM — Original Application (PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS)
FDA approved an original ANDA for rosuvastatin calcium, enabling a generic version of rosuvastatin calcium manufactured by Puracap Laborator…
-
FDA approval · 2016-10-31FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved the Original Application for rosuvastatin calcium from Westminster Pharmaceuticals, LLC, granting a generic rosuvastatin calciu…
-
FDA approval · 2016-07-19FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Glenmark Pharmaceutials Inc., USA)
FDA approves rosuvastatin calcium as an original generic application from Glenmark Pharmaceuticals Inc., USA.